SRRA added some more shares here. Next week could be fun!
Sierra Oncology, Inc. SRRA, +0.00% a clinical stage drug development company focused on advancing next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer, today announced it will host a Program Update on Tuesday, February 27(th) from 10:00 a.m. - 12:00 p.m. Eastern Time (ET) at the Lotte New York Palace in New York, NY.